Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Medicine, Gynecology, Oncology +16

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

David S. Alberts, P. Y. Liu, Edward V. Hannigan et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

Medicine, Oncology, Surgery +5

TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS

A. A. Epenetos, S. J. Mather, M. Granowska et al. · The Lancet · 1982 · 399 citations

Medicine, Nuclear Medicine, Oncology +9

Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms.

Agamemnon A. Epenetos, Deborah Snook, H. Durbin et al. · PubMed · 1986 · 284 citations

Medicine, Nuclear Medicine, Oncology +17

Long-term survival in ovarian cancer

J.P. Neijt, W.W. ten Bokkel Huinink, M.E.L. van der Burg et al. · European Journal of Cancer and Clinical Oncology · 1991 · 213 citations

Medicine, Oncology, Surgery +14